Table 3. Reported prevalence of ANA in many conditions

Autoimmune rheumatic diseases	%
SLE	97–100
Drug-induced LE	> 99
MCTD	> 99
Sjögren syndrome (SjS)	85
Systemic sclerosis (SSc)	81–97
IIM (e.g., DM/PM)	40–80
Juvenile idiopathic arthritis (JIA)	20–50
Rheumatoid arthritis (RA)	30–50
Autoimmune hepatitis	45–60
Autoimmune thyroiditis	30–50

Infectious/malignant diseases	%
Endocarditis	47
Epstein-Barr virus	44–66
Human immunodeficiency virus	21–23
Tuberculosis	24–33
Non-Hodgkin lymphoma	26
Ovarian cancer	40

Healthy subjects	%
≥ 1:40	20–30
≥ 1:80	10–15
≥ 1:160	~5

SLE: systemic lupus erythematosus; MCTD: mixed connective tissue disease; IIM: idiopathic inflammatory myopathy; DM/PM: dermatomyositis/polymyositis.